ACADIA PHARMACEUTICALS A/S: Financial statements 2014
CVR: 19670694
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ACADIA PHARMACEUTICALS A/S (CVR 19670694) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK -146,995 compared with DKK -57,074 the year before. Equity in the 2014 report amounted to DKK -213,871.
- Profit/Loss
- DKK -146,995
- Equity
- DKK -213,871
- Total Assets
- DKK 8,590
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | - | -147 t. | -214 t. | - |
| 2013 | - | - | -57 t. | -67 t. | - |
| 2012 | - | - | -258 t. | -10 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
ACADIA PHARMACEUTICALS A/S has published its annual report for 2013. The net result was DKK -57,074.
As of May 26, 2014, Glenn Frederick Baity has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 26, 2014, Thomas Aasen has left the board of directors of ACADIA PHARMACEUTICALS A/S.
About ACADIA PHARMACEUTICALS A/S
ACADIA PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1996. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RECEPTOR TECHNOLOGIES A/S and VICH 4861 A/S. The management consists of Jennifer Jane Rhodes. The board consists of Martin Choy (chair), James Kenji Kihara, Jennifer Jane Rhodes and Peter Francis Chae. The company is owned by Acadia Pharmaceuticals Inc.. The company has 6 employees (2005). In 2025, the company reported a net result of DKK -471,043 compared with DKK -99,365 the year before. Equity in the 2025 report amounted to DKK -1,563,180.